Close Menu

Xiamen University

The single-tube, multiplex qPCR assay is the second CE-marked test in the firm's MeltPro line, and identifies 14 genotypes of human papillomavirus.

The test uses multicolor high-resolution melt analysis to detect mutations that lead to a potentially fatal blood disorder particularly common in Asian populations.

Scientists from a number of Chinese research institutions and government agencies have published the first peer-reviewed paper describing the clinical validation of a tuberculosis drug-resistance assay developed by Xiamen-based molecular diagnostics firm Zeesan Biotech.

This article has been updated from a previous version to clarify information regarding the development and commercialization of Zeesan Biotech's assays.

Having recently secured funding from a private investor, moved to the San Francisco Bay Area, and obtained the rights to a key patent covering its core nucleic acid probe technology, molecular diagnostics startup QuanDx is now shifting its attention toward developing clinical ass

Scientists from China's Xiamen University and a startup company called Xiamen Zeesan Biotech have submitted the test to Chinese regulatory officials for approval as a widespread prenatal diagnostic and screening tool for β-thalassemia.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.